Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07543601

Enhanced COPD Management in Suspected Lung Cancer Patients

Led by Ditte Krag-Hansen · Updated on 2026-04-22

280

Participants Needed

1

Research Sites

68 weeks

Total Duration

On this page

Sponsors

D

Ditte Krag-Hansen

Lead Sponsor

A

AstraZeneca

Collaborating Sponsor

AI-Summary

What this Trial Is About

Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates. This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle. The findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.

CONDITIONS

Official Title

Enhanced COPD Management in Suspected Lung Cancer Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Undergoing diagnostic evaluation for suspected lung cancer
  • Spirometry showing obstructive airflow limitation (FEV1/FVC < 75% or FEV1 < 80%, and no reversibility) at the first outpatient visit at the lung cancer evaluation
Not Eligible

You will not qualify if you...

  • Presence of significant comorbidities that may interfere with diagnostic procedures or spirometry
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Lung Cancer Investigation Unit, Lillebaelt Hospital Vejle

Vejle, Denmark, 7100

Actively Recruiting

Loading map...

Research Team

D

Ditte Krag-Hansen, MD, PhD student

CONTACT

M

Morten Hornemann Borg, MD, PhD, Chief consultant

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here